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The objective of this study was to assess the effect on health-related quality of life of acupuncture and sham acupuncture as
adjunctive treatment in intractable epilepsy. We performed a randomized controlled trail with two parallel treatment arms at The
National Center for Epilepsy in Norway, a comprehensive epilepsy center. Thirty-four patients with long-standing drug resistant
epilepsy completed the study. The intervention consisted of 20 acupuncture treatments (bilateral needling of three acupoints plus
one or two individually chosen points) or sham acupuncture (bilateral needling with smaller needles of three points outside the
traditional meridians) over 8 weeks. The main outcome measures were changes in mean health-related quality of life scores for
the two groups after 8 weeks, using the 89-item Quality of Life in Epilepsy (QOLIE-89) questionnaire. We found no difference
between the acupuncture and sham acupuncture groups in score changes in any dimension of the QOLIE-89 questionnaire,
despite testing a large number of dimensions. We also found no change in QOLIE-89 scores between baseline and 8 weeks in
either groups. In conclusion, we could not demonstrate a significant effect of traditional acupuncture or sham acupuncture on
the health-related quality of life of patients with intractable epilepsy.
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INTRODUCTION
In traditional Chinese medicine acupuncture has been
used to treat a number of different diseases, includ-
ing epilepsy1, 2. Acupuncture has been used against
experimental epilepsies in animals3, 4, and auricular
acupuncture has been used for intractable idiopathic
epilepsy in dogs5. From work on animal models it has
been suggested that the mechanism of acupuncture in
suppressing epileptic seizures is through the release
of neurotransmittors, such as endogenous opioid pep-
tides, serotonin and gamma-butyric acid6. However, it
remains unclear whether this would be specific to cer-
tain types of epilepsy.
In humans the efficacy of scalp needling7, elec-
troacupuncture8 and catgut embedding in acupoints
in treating epilepsy is reported9, and successful treat-
ment of status epilepticus with acupuncture is reported
in eight cases10. Recently some of our patients with
epilepsy travelled to China on their own for acupunc-
ture treatment, and some reported good results.
Thus, both theoretical and practical considerations
suggested the possibility of a beneficial effect of
acupuncture in epilepsy. However, we could not
find documented controlled trials of the efficacy of
acupuncture in treating epilepsy. We have recently re-
ported a lack of beneficial effect of acupuncture on
seizure frequency and EEG findings11. The present
study is an extension of this study, assessing the im-
pact of acupuncture on the health-related quality of life
(HRQL) in patients with intractable epilepsy.
METHODS
Patients
Patients were recruited from the outpatient popula-
tion of The National Center for Epilepsy, Norway, all
of them suffering from chronic intractable epilepsy.
Inclusion criteria were age ≥18 years, duration of
epilepsy >2 years, partial or generalized epilepsy and
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one or more seizure per week. Exclusion criteria were
non-epileptic seizures alone or in combination with
epilepsy, progressive cerebral illness or inability to co-
operate in the study.
Forty-one patients were eligible for the study. Seven
patients withdrew during the baseline period, but be-
fore randomization, because they found participa-
tion inconvenient. Thirty-four patients were included
in the study and randomized to the two treatment
groups. Eighteen patients received acupuncture treat-
ment, while 16 received sham acupuncture. During the
study, one patient in each group was hospitalized and
had changes in their medication. No patients dropped
out after randomization.
At baseline the two treatment groups were compa-
rable with regard to age, gender, duration of epilepsy,
age at onset of epilepsy, seizure frequency and propor-
tion of patients who previously had had acupuncture
(Table 1).
Study design
The study included a baseline period of 10 weeks,
a treatment period of 8 weeks and follow-up for
the quality of life data after another 4 weeks. After
the baseline period, the patients were randomized to
acupuncture or sham acupuncture through a restricted
randomization procedure, using block randomization
with blocks of four patients12.
All patients were treated on an outpatient basis and
received 20 treatments (three treatments per week for
3.5 weeks, 1 week pause and another series of treat-
ments over 3.5 weeks). Each treatment lasted about
30 minutes.
Both acupuncture and sham acupuncture treatments
were administered by two experienced acupunctur-
ists, both being staff members of the Shanghai Uni-
versity of Traditional Chinese Medicine. Each patient
was treated by the same acupuncturist throughout the
study.
To control factors which could affect the outcome,
current antiepileptic and co-medication were held sta-
ble and monitored during baseline and follow-up. Both
patients and epileptologists were blinded. The study
was approved by the Regional Ethics Review Commit-
tee. Informed consent was obtained after both verbal
and written information.
Acupuncture technique
The acupuncture treatment given was administered ac-
cording to the method used at the Shanghai University
of Traditional Chinese Medicine. All patients were di-
agnosed according to the principles of traditional Chi-
nese medicine. One of five main diagnoses was given
to each patient, and they were all treated by bilat-
eral needling of the acupoints LR3, LI4 and GV2013,
in addition to one or two points based on individ-
ual diagnosis. The needles used were traditional Chi-
nese acupuncture needles, diameter 0.3 mm and length
25–55 mm (1–2 cun, most often 1.5 cun; cun is an
individual system of measurement used in traditional
Chinese medicine, familiar to acupuncturists around
the world) and placed at variable depths. The needles
were rotated or stimulated manually in order to ob-
tain the needling sensation (Te chi). As part of this in-
dividualized treatment the patients could have scalp-
needling or electroacupuncture using a standard tran-
scutaneous nerve stimulation apparatus with acupunc-
ture needles as electrodes. For electroacupuncture we
used an Elpha 2000 instrument (Biometer Interna-
tional As, DK-5210 Odense, Denmark) at 3 Hz and
3–20 mA.
Sham acupuncture technique
Sham acupuncture was given as bilateral needling of
three sham acupoints chosen by a group of Chinese
and Norwegian acupuncturists: S1 (sham1)—2.5 cun
to the side of the umbilicus, S2—3 cun above the
midpoint of the patella, S3–1 cun below the midpoint
between LI15 and TE1413. In the sham group we
used thinner needles (0.25 mm diameter and 0.5 cun
length), which were placed at a depth of 0.3 cun, and
were stimulated neither manually nor with electric cur-
rent.
Assessment of health-related quality of life
HRQL was evaluated with a Norwegian translation of
the 89-item Quality of Life in Epilepsy questionnaire
(QOLIE-89)14, 15, administered at baseline and after
8 weeks of treatment. The QOLIE-89 questionnaire
consists of a generic core, the RAND 36-item Health
Survey 1.0, also known as the Short Form 36 (SF-
36)16, 17, and a collection of items believed to be more
specific and relevant for epilepsy14, 15. The QOLIE-89
questionnaire assesses HRQL during the last 4 weeks.
It has 17 different multi-item scales, which in addition
are aggregated into an overall score. Reliability and
validity of the Norwegian version of the QOLIE-89
has previously been reported18.
Statistical analysis
Statistical analyses were carried out under the princi-
ple of intention to treat. For comparison of baseline
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Table 1: Characteristics at baseline of subjects treated with sham acupuncture or acupuncture
Sham Acupuncture p-valuea
Number of subjects 16 18
Men/women 7/9 9/9 0.74
Age, years (mean ± SD) 37.4± 15.0 37.7± 12.8 0.95
Age at onset, years (mean ± SD) 12.9± 10.9 10.8± 6.5 0.49
Duration of epilepsy, years (mean ± SD) 26.4± 12.1 27.6± 14.3 0.80
Number of antiepileptic drugs in use (mean ± SD) 2.3± 0.8 2.0± 0.8 0.28
Median weekly number of seizures,
median (interquartile range) 2.0 (14.8) 3.5 (5.5) 0.51b
No (%) who previously had acupuncture 4 (25%) 4 (22%) 1.00
No (%) who had visited homeopath or healer 2 (14%) 5 (28%) 0.41
Seizure type 0.08
primary generalized 5 1
partial with generalization 11 17
a Independent samples t-test for comparisons of means, Fisher’s exact test for comparisons of proportions; b Mann-Whitney U -test.
Table 2: QOLIE-89 scores at baseline, raw scores and transformed scoresa
Raw scores T -scores
Sham Acupuncture Sham Acupuncture
Mean SE n Mean SE n p-valueb Mean SE Mean SE
Attention/concentration 64.3 3.2 16 66.9 4.6 18 0.65 47.2 1.5 48.5 2.2
Emotional well-being 61.3 4.3 16 57.4 4.5 17 0.53 47.0 2.2 44.9 2.3
Energy/fatique 54.4 7.0 16 43.8 4.2 17 0.20 49.6 3.3 44.6 2.0
Health discouragement 70.0 7.5 16 65.9 7.3 17 0.70 50.1 2.7 48.6 2.6
Health perception 69.1 5.3 16 60.4 5.4 18 0.26 50.4 2.7 46.0 2.8
Language 77.6 3.9 16 71.8 6.5 17 0.46 51.4 1.8 48.7 3.1
Medication effects 64.3 6.5 15 55.4 7.3 17 0.37 52.9 2.1 50.0 2.4
Memory 53.9 6.0 16 54.9 6.9 18 0.91 48.8 2.5 50.3 2.9
Pain 74.7 7.0 16 64.9 5.3 18 0.27 49.7 2.8 45.7 2.2
Physical function 89.4 3.7 16 79.2 5.3 17 0.13 52.1 1.9 46.9 2.7
Overall quality of life 59.4 5.8 16 57.2 5.0 18 0.47 45.8 3.2 44.6 2.7
Role limitations—emotional 61.3 9.6 16 62.5 7.3 16 0.92 47.7 2.8 48.0 2.1
Role limitations—physical 60.6 8.5 16 50.6 8.4 17 0.41 47.9 2.5 45.0 2.4
Seizure worry 65.3 6.5 16 60.5 5.9 18 0.59 52.7 2.5 50.9 2.3
Social isolation 72.7 5.2 15 79.4 5.3 18 0.38 48.4 2.1 51.1 2.1
Social support 63.8 5.9 16 72.2 5.3 18 0.30 46.2 2.6 49.9 2.3
Working/driving/social function 58.0 3.9 16 61.1 4.9 18 0.63 46.1 1.7 47.5 2.1
Overall score (total score) 63.9 3.3 14 63.1 4.7 14 0.89 47.4 2.1 46.9 3.0
SE, standard error. a transformed scores (T -scores) for comparison with an American reference population of epilepsy patients with mean
score of 50, SD 10; b independent samples t-test.
patient characteristics and HRQL scores, we used an
independent samples t-test for comparisons of means
and Fisher’s exact test for comparison of proportions.
Mann-Whitney U -test was used for comparison of
seizure frequencies because of skewed distributions.
The effect of acupuncture treatment was assessed as
the difference in HRQL scores, using the QOLIE-89
instrument, between questionnaires filled in at base-
line and after 8 weeks of treatment. We compared
the mean difference in score changes from baseline
to 8 weeks for the two groups using a t-test for inde-
pendent samples. Additionally, score changes for the
QOLIE-89 dimensions were assessed for the acupunc-
ture group and sham acupuncture group separately, us-
ing a one sample t-test. We chose a 5% significance
level.
In this study we included 34 patients, which gives
the study a power of 80% to detect a mean difference
between groups of 1 SD on the HRQL scales.
RESULTS
At baseline there was no significant difference be-
tween the sham group and the acupuncture group in
any of the QOLIE-89 dimensions (Table 2). Baseline
QOLIE-89 scores were transformed to be compara-
ble with an American reference population of mild to
moderate epilepsy patients, with a mean score of 50
and standard deviation of 1014, 15. The patients in our
study had slightly lower mean scores than this Ameri-
can reference population (Table 2).
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Table 3: Mean changes in QOLIE-89 scores from baseline to 8 weeks, after 8 weeks of intervention
Sham (S) Acupuncture (A) Difference 95% CI for
(n = 13–16) (n = 16–18) (A–S) difference p-valuea
Attention/concentration 8.6 2.0 −6.5 −18.9 to 5.8 0.29
Emotional well-being −0.7 −1.4 −0.7 −11.0 to 9.6 0.89
Energy/fatique −1.3 −4.4 −3.1 −21.2 to 15.0 0.73
Health discouragement 5.3 1.2 −4.2 −22.9 to 14.6 0.65
Health perception 2.6 3.8 1.2 −7.7 to 10.2 0.78
Language 1.5 8.2 6.7 −5.5 to 18.9 0.27
Medication effects −7.4 −1.6 5.8 −11.8 to 23.5 0.51
Memory 8.0 4.5 −3.5 −16.6 to 9.5 0.58
Pain −1.6 5.7 7.3 −13.7 to 28.2 0.49
Physical function −1.0 0.2 1.2 −8.6 to 11.0 0.81
Overall quality of life 6.9 −1.0 −7.9 −20.1 to 4.4 0.20
Role limitations—emotional −9.2 −9.1 0.2 −26.9 to 27.3 0.99
Role limations—physical −3.3 −1.5 1.9 −26.3 to 30.0 0.89
Seizure worry 1.0 −1.6 −2.5 −15.2 to 10.2 0.69
Social isolation 9.3 −2.4 −11.6 −27.3 to 4.0 0.14
Social support 3.4 −8.7 −12.1 −27.8 to 3.6 0.13
Working/driving/social function 0.0 0.2 0.2 −9.3 to 9.7 0.96
Overall score (total score) 1.7b −1.7c −3.4 −14.4 to 7.7 0.53
95% CI, 95% confidence interval. a t-test; b n = 10; c n = 12.
Between baseline and the end of the intervention pe-
riod of 8 weeks, there was no significant difference in
score changes between the two intervention groups on
any of the QOLIE-89 scales (Table 3). When analyz-
ing the two groups separately, there were no signifi-
cant changes from baseline to 8 weeks in any QOLIE-
89 dimension in either the sham acupuncture or the
acupuncture group.
DISCUSSION
In this study of adjunctive treatment with acupuncture
or sham acupuncture, we found no significant differ-
ence in HRQL score changes between the two inter-
vention groups over the course of an 8 week treatment
period, and we could not detect a change from baseline
in either group. This is in agreement with the seizure
frequency data previously published from this study11.
We are not aware of other controlled studies of
acupuncture treatment of epilepsy similar to our study.
Other studies of acupuncture report a similar needle
placement as used in our study, also using LR3, LI4
and GV20 among the acupoints10 and a similar tech-
nique of electrostimulation8. In clinical practice in
China there seems to be a tendency to choose points on
the Governor vessel and scalp, preferably with electri-
cal stimulation1.
Choice of placebo or intervention for the control
group in trials of acupuncture is controversial. In 28
controlled studies, 28 different acupuncture placebos
were used19, making comparisons between studies dif-
ficult. In this study we chose to use needling as treat-
ment of the control group, using a minimalist ap-
proach: piercing the skin outside the usual acupunc-
ture points, using fine needles without any stimulation,
and not obtaining the needling sensation.
There are several limitations to our study. One limi-
tation is the small sample size, which only would en-
able us to detect differences of 1 SD, which normally
is a very large difference. With a larger sample size we
might have detected smaller differences at the chosen
power level.
There were variations in the treatments given and the
acupoints used within the groups; however, this het-
erogeneity is a part of traditional Chinese acupuncture.
Our patients had chronic and drug resistant epilepsies,
they were heterogeneous with regard to seizure type
and frequency and they clearly are not representative
for the total population of patients with epilepsy.
Several aspects of the QOLIE-89 questionnaire have
not yet been tested. Tests of longitudinal change or re-
sponsiveness of this measure are lacking, as for many
other instruments for assessing HRQL. Despite the
many limitations of such instruments, we think mea-
sures of functional status and well-being are important
measures of clinical trial outcomes in chronic diseases.
In conclusion, in this trial we were not able to detect
significant changes in HRQL either with the acupunc-
ture treatment or with the sham acupuncture.
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